Europe’s Beating Cancer Plan: the importance of initiatives to improve the quality of life of cancer patients and survivors
On 31 January 2024, the Europe's Beating Cancer Plan conference took place in Brussels. The Plan is one of the funding pillars of the European Health Union and focuses, among other, on improving the quality of life of cancer patients and survivors.
BD4QoL Expands Patient Enrollment, Overcomes Challenges, and Advances Mobile App Usage with DOTSOFT Support
In a significant milestone for the groundbreaking European project BD4QoL, the consortium proudly announces a substantial increase in patient enrollment from partner clinical sites. This surge underscores the growing impact of BD4QoL in reshaping post-treatment experiences for individuals who have overcome head and neck cancer.
How digital technologies are changing the way in which evidence is generated in Medicine
Through its involvement in BD4QoL, CSS partner has gained valuable insights into how emerging digital technologies can impact the generation of evidence in medicine. The traditional gold standard for demonstrating the safety and efficacy of a clinical intervention, particularly when involving drug administration, has been the principles of Evidence-Based Medicine (EBM).
INT - UMIL attending the Health & Tech Summit 2023
INT - UMIL partners are going to present at the Health & Tech Summit 2023 the technological solutions developed and used in the prospectic clinical study for remote monitoring H&N patients QoL. The conference updates on topics such as AI, Big data and cutting-edge technologies in the healthcare sector.
Participating in the BD4QoL project can represent a sign of hope for patients to return to a normal life
During the follow-up visits scheduled in the BD4QoL project, the CSS team has observed that some enrolled patients, upon completing treatments, have managed to return to a lifestyle close to normalcy and resume work, albeit with limitations due to changes they had to make in their lifestyle due to the illness.
Embracing the Future of Health: Following the steps of BD4QoL
In a world where personalized well-being takes center stage, BD4QoL pioneers a groundbreaking approach for those navigating life after Head and Neck Cancer treatment. Imagine a future where wearables and personal devices seamlessly intertwine with Big Data-driven AI algorithms, fostering real-time monitoring and support for individual Quality of Life (QoL).
BD4QoL attending the FAITH project networking event “AI in Healthcare”
BD4QoL attended the networking event “AI in Healthcare”, dedicated to artificial intelligence in the healthcare domain. How should artificial intelligence (AI) applications be introduced in the healthcare domain? What are the challenges faced so far, and what has been overlooked?
Ensuring privacy and access to data in the BD4QoL project
The aim of the European project BD4QoL is to improve the quality of life of people who have overcome a head or neck cancer, through individual monitoring and follow-up of patients. In order to carry out this task successfully, daily data on the activities and habits of the participants are collected through mobile applications, which allow the development of personalized interventions on individuals during treatment to prevent risks and avoid negative effects derived from the disease.
Lombardy Region and ARIA holding a workshop with patients' associations
On October 17th, Lombardy Region and ARIA are holding a workshop with patients' associations in order to present the digital solutions developed in BD4QoL. More stakeholders will attend the meeting such as service providers, BD4QoL Partners, patients involved in the projects, policy makers and clinicians.
Inequalities in returning to work after H&N cancer
Starting from a cohort of residents in Turin (Piedmont, Italy) from 2008 to 2018 it was possible to select 255 incident cases of H&N cancer related to workers in the year of diagnosis, who had no cancer in other sites in the considered period. Within this subset, about 34% of patients didn’t work during the two years after the diagnosis.
Measuring behaviour for patient self-empowerment: Android vs iOS platforms
One of the results of the BD4QoL market analysis has been the appreciation of differences existing among the two major mobile OS platforms – iOS and Android – when it comes to behaviour measurement, which is needed to implement several mHealth applications that target patient empowerment and self-care.
Dissemination of BD4QoL project scope and results within the scientific event held in Ioannina, Greece about Smart-Health
A scientific event on SMART HEALTH was held in Ioannina on May 26, 2023. This project focuses on developing an expert system for automating the diagnosis of learning and communication disabilities in children.
DOTSOFT demonstrate the mobile app in the 16th EAI International Conference on Pervasive Computing Technologies for Healthcare
DOTSOFT participated in the 16th EAI International Conference on Pervasive Computing Technologies for Healthcare that took place between 12-14 December 2022 in Thessaloniki, Greece
Quality rules set to evaluate the mHealth BD4QoL mobile app
The BD4QoL mobile app has been used for more than three months from patients that have survived from Head and Neck Cancer, in the scope of a clinical trial. A set of rigorous and appropriate criteria have been chosen and quality rules automatically generate related clinical trial evaluation results. The process of evaluating the health app is ongoing and a full set of results is expected in the next 24 months.
The Bidi chatbot is recognised by the European Commission’s Innovation radar project
The Innovation Radar is a European Commission initiative that aims to identify and highlight Innovations with high potential from EU funded research projects. The Bidi chatbot, which provides a natural language interface for HNC survivors to ask questions, get health tips and report symptoms to their point of care was highlighted by the Innovation Radar.
BD4QoL prospective clinical trial: patient enrollment started in “Casa Sollievo della Sofferenza” hospital
The “Casa Sollievo della Sofferenza” hospital (S. Giovanni Rotondo, Italy) started the enrolment of the patients who participate in the prospective trial for the use of the BD4QoL platform starting from April 11th, 2022.
BD4QoL access to EU-funded Horizon Results Booster (HRB) services
BD4QoL will partner with the EU-funded H2020 project CAPABLE in sharing results and recommendations for the successful dissemination of new Artificial Intelligence assisted technologies for cancer patients quality of life monitoring and support.
First results for the BD4QoL semantic-location based point of interest identification mechanism published
A paper from the BD4QoL partner DEUSTO “Location Based Indoor and Outdoor Lightweight Activity Recognition System” has been published in the Electronics Journal, including the first results for the BD4QoL semantic-location based point of interest identification mechanism.
BD4QoL mentioned during the IAG-KHT Spring Symposium “Head and neck tumours in the focus of health services research”!
The BD4QoL project has been mentioned during the IAG-KHT Spring Symposium “Head and neck tumours in the focus of health services research” organised by the German Cancer Society Interdisciplinary Group on head and neck cancer and held on April 27th, 2022, at the Berlin VKU Congress center.
BD4QoL Project is online on the AIOM website!
The Clinical Study carried out in the context of the BD4QoL Project - Multicentre randomised clinical trial to assess quality of life using non-invasive electronic devices during post-curative follow-up for head and neck cancers – is now online on the AIOM (Associazione Italiana di Oncologia Medica) website!
Highlighting innovations: the BD4QoL project in the European Commission's Innovation Radar!
The innovation “BD4QoL Point of Care (PoC) support tool for healthcare professionals following up Head and Neck Cancer (HNC) survivors” developed in the project has been selected by the European Commission's Innovation Radar
2021 ESMO AWARDS - recognising excellence in oncology
Precision oncology is the goal today, not a simple slogan Prof. Lisa Licitra: “Truly pursuing precision medicine means pushing the boundaries of patient selection using molecular biology and artificial intelligence on all big data, not just molecular information”
Oral presentation at EMBS2020
Abstract: The cancer-related mortality is decreasing in recent times bringing the number of people living with cancer is increased. In this sense, ICT could support clinicians in the follow-up of cancer patients are essential. This paper presents the outcomes from the scoping review of PoC existing solutions.
Poster presentation at ESMO2020 conference.
Paper title: Research and contextual inquiry on information and communication technologies point of care systems for cancer follow-up. This work presents the outcomes from a research work conducted for Point of Care (PoC) systems applied in cancer follow-up.